Minghai Wang

5PUBLICATIONS
3CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 04, 2026
Pharmaceutical Potential of Antibody-Drug Conjugate Doublets for Targeted Treatment of Cancers Heterogeneously Expressing RON Receptor Tyrosine Kinase.

|Jan 21, 2025
Humanized dual-targeting antibody-drug conjugates specific to MET and RON receptors as a pharmaceutical strategy for the treatment of cancers exhibiting phenotypic heterogeneity.

Minghai Wang, Qi Ma, Sreedhar Reddy Suthe

|Sep 15, 2019
Therapeutic efficacy of a novel humanized antibody-drug conjugate recognizing plexin-semaphorin-integrin domain in the RON receptor for targeted cancer therapy.

Xiang-Min Tong, Liang Feng, Sreedhar Reddy Suthe

|Mar 16, 2019
Therapeutic efficacy, pharmacokinetic profiles, and toxicological activities of humanized antibody-drug conjugate Zt/g4-MMAE targeting RON receptor tyrosine kinase for cancer therapy.

Hang-Ping Yao, Liang Feng, Sreedhar Reddy Suthe

|Jun 27, 2018
Preclinical Efficacy of Anti-RON Antibody-Drug Conjugate Zt/g4-MMAE for Targeted Therapy of Pancreatic Cancer Overexpressing RON Receptor Tyrosine Kinase.

Hang-Ping Yao, Liang Feng, Tian-Hao Weng

Pageof 1

Frequent Collaborators

2 joint publications

Hang-Ping Yao

1 joint publications

Durga Puro

1 joint publications

Sreedhar Reddy Suthe